DNA2 and breast cancer: Given the clinical attribute of DNA2 mRNA expression in breast cancer, we sought to assess the relationships between DNA2 protein expression and clinicopathologic indicators via immunohistochemical (IHC) staining in 26 breast cancer tissues and 7 breast benign tissues (the clinical characteristics is shown in Table S1).